Motilal Oswal's research report on Coromandel International
CRIN’s operating performance beat our estimate, largely led by strong volume growth of 21% YoY in total manufactured phosphatic fertilizer (DAP & NPK) to 0.91MMT (est. 0.83MMT) and better EBITDA/MT. Better margins were on account of backward integration, better outsourcing of raw materials, and favorable agricultural environment in most of its key operating markets.
Outlook
Factoring in strong 3QFY23 operating performance, we raise our EBITDA estimates for FY23/FY24/FY25 by 6%/5%/7%, respectively, on improving EBIDTA/MT of fertilizer business. We value the stock at 16x Dec’24 EPS to arrive at our TP of INR1,180. We reiterate our Buy rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.